- Conditions
- Scopolamine, Motion Sickness
- Interventions
- Scopolamine, Placebo
- Drug
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Other
- Eligibility
- 21 Years to 49 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
Source: ClinicalTrials.gov public record
Updated Aug 27, 2025 · Synced May 21, 2026, 5:31 PM EDT